Workshop C: Preventing Serious Injuries & Fatalities in Biopharma Through Risk Assessment, Critical Control Verification & High-Risk Work Management

Move beyond traditional incident metrics to proactively identify and prevent Serious Injuries and Fatalities (SIFs) across biopharma laboratories, manufacturing facilities and construction projects.

This hands-on workshop will provide practical approaches to identifying high-consequence hazards, assessing SIF potential and strengthening critical safety controls across activities including hazardous energy isolation, confined space entry, hot work and contractor operations. Through realistic biopharma scenarios and interactive exercises, apply bowtie risk assessment methodologies to map potential incident pathways, identify preventative and mitigating barriers, and evaluate where critical controls could fail. Explore how to establish effective control verification processes, assign accountability and use leading indicators to identify weaknesses before

serious incidents occur. Leave with actionable risk assessment frameworks, critical control verification checklists and practical strategies for prioritising high-risk activities to prevent serious harm across your organization.

Speakers: